Header Logo

Connection

Michael Machiorlatti to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Michael Machiorlatti has written about Antibodies, Monoclonal, Humanized.
Michael Machiorlatti
Connection Strength
0.149
Antibodies, Monoclonal, Humanized
  1. Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.